Our commitment to security, safety and responsible use of clinical data for practices and patients.
For decades, medical professionals across Australia have been using Genie® and Gentu® in their practice. Magentus is also a trusted provider of clinical software for medical oncology, laboratory information management, and radiology across Australia and the UK. To meet modern needs, our software is evolving from storing data to intelligently processing, prompting, summarising, and suggesting. With these advanced capabilities, it’s essential that customers and patients understand how data is used, how AI is applied, and how privacy is protected. Central to this is ensuring clear consent to participate or the ability to opt–out of these data and AI solutions.
Our Charter lies at the heart of what we do in the field of data, analytics and artificial intelligence. Core to this Charter are the following principles:
User and patient value are paramount in all decisions related to data and artificial intelligence usage and we prioritise activities that are directly designed to improve patient care and outcomes.
Via this Trust Centre and otherwise, we maintain clear communication with our customers about how data and artificial intelligence drive improved user experience with our products and provide the health care ecosystem with aggregated insights on population health.
Security and trust are at the very core of how we operate and constantly evolve. Our information security management system is ISO27001:2022 certified. We implement advanced technical safeguards throughout our data architecture. Privacy controls are embedded in our systems from initial design stages, and we regularly review and enhance our security protocols.
In instances where large language models are applied to create structured data outputs from unstructured data sources, data is first de-identified before the language models are applied.
For external data and AI solutions where insights are provided to project sponsors, or in conversations with Government Health Departments, where we may use data-based insights to advocate on our customers’ behalf, data is aggregated to protect the anonymity of practices, health care professionals and their patients.
Our privacy policy can be viewed here.
We will only ever use data and artificial intelligence for reasons that are aligned to our objective of delivering better healthcare outcomes through world-class technology. Our Chief Medical Officer has oversight of all our data and AI solutions and ensures that we are only using data for this purpose. A panel of clinical experts and practicing healthcare professionals from a range of specialties advise Magentus on data and artificial intelligence solutions on a regular basis. This advisory panel undertakes careful assessment of proposed uses of data and artificial intelligence to provide a clinical perspective on its appropriate use.
Where our external data and AI solutions assist a project sponsor in conducting research, we recommend that the project sponsor apply the principles of the National Statement on Ethical Conduct in Human Research (2025) including those related to seeking review by a Human Research Ethics Committee (HREC). We assist our project sponsors on applications to a HREC with respect to the data collection applied within our external data and AI solutions.
Our data and artificial intelligence practices comply with relevant legal and regulatory requirements. We participate in industry standard-setting initiatives and adhere to the international FHIR framework for healthcare data interoperability.
Technology is evolving rapidly, and Magentus as your trusted practice partner wants to make sure you can access innovation, but only when you feel comfortable.
Magentus offers two distinct types of innovation-driving Data Projects, and we want to be transparent about how each works. Internal Data Projects are built-in functional enhancements to your Genie or Gentu product that require Magentus to access data. These projects, enabled by default, can unlock future features for your practice, such as smarter patient summaries or clinical decision support tools.
External Data Projects form part of our voluntary Magentus Research Program, whereby data is de-identified and then aggregated to generate insights for research and broader health outcomes improvement. No practice is included in any External Data Project without that practice’s explicit consent.
By clearly distinguishing Internal vs External Data Projects in this way, Magentus aims to give you full control and confidence over how your data is used. If you have any questions or wish to change your participation status in either type of project, visit our FAQ below or contact [email protected].
At Magentus we’re trying to create a future where healthcare networks are optimised for better care, harnessing the full potential of health technology and constant innovation. We believe that data can be responsibly and safely used to improve the lives of patients. By developing a data platform and leveraging the power of AI, we believe we can give practices and healthcare organisations access to deeper insights, so they can provide more efficient and more informed healthcare.
Some internal data and AI solutions like clinical decision support will seamlessly be made available to practices through its Magentus practice management software and will be covered by the software’s master services agreement with us. Other internal data and AI solutions (for instance where ambient scribe is used) will require the Practice to accept additional terms and these will be provided at the point in time where the Practice is attempting to access these solutions. If a practice would like to opt out of any solutions at any time, it can contact [email protected].
Participation in the Magentus Research Program will require the authorised representative of a practice to explicitly opt-in. This can be done via the prompting that will occur within the practice’s Magentus software. When an authorised representative opts-in, all data from the practice that is stored within the practice’s Magentus software will be made available to the program. If you would like to change your participation election, you can email [email protected] at any time.
A practice is responsible for securing the relevant patient consent for Magentus to provide the practice with practice management software inclusive of data and AI solutions. Whilst it is up to the practice to obtain its own legal advice on data and artificial intelligence usage within the practice, we have provided some suggested language for inclusion in a practice’s new patient onboarding forms to ensure the practice’s patients are aware that these types of solutions are being employed in delivering care to them – please refer to the “Patient Consent” section above.
In conversations with your patient around data use, it is relevant to advise them that no personal information is provided into large language models for the purposes of data structuring for data usability purposes and that no data from the practice is used to train these models. Should the practice choose to opt-in to external data and AI solutions, only very de-identified and aggregated information is provided to project sponsors or other third parties.
If a patient would like to opt out of data and AI solutions (whether internal or external), the patient should advise their practice/practitioner, who should in turn advise us of the patient’s election by contacting us at [email protected].
A practice can always change its election with respect to participating in data and AI solutions (whether internal or external) by contacting us at [email protected].
We carefully select who we work with and the projects that we undertake to ensure they align with our values and vision of improving patient outcomes. These may include universities, pharmaceutical companies, medical device companies, research organisations, and government agencies. If there is a project that a practice is interested in undertaking via the Magentus Research Program, please get in touch via [email protected].
We will only ever use data for the goal of improving patient outcomes. Our Chief Medical Officer has oversight of all our data and AI solutions and ensures that we are only using data for these purposes. We have a panel of clinical experts and practicing healthcare professionals from a range of specialties who advise us on our data and AI solutions on a regular basis. This advisory panel undertakes careful assessment of proposed uses of data to provide a clinical perspective on its appropriate use. We will provide updates on future developments, improvements and opportunities over time to keep all practices informed.
Magentus will not directly sell practice data or any patient personal information. However, if a practice chooses to opt-in to the Magentus Research Program as part of our external data solutions, we may use de-identified data to create aggregated insights that are then provided to project sponsors in return for a commercial benefit. Not all projects will involve a commercial benefit, and we may use data as part of the external data solutions to provide insight back to our customers or to government departments and agencies in a way that allows us to advocate on behalf of our customers.
By participating in in the Magentus Research Program a practice will be assisting in the development of more efficient ways of conducting research that make use of pooling routinely collected information across the breadth of Magentus’ practice management user base. Wherever possible, insights that are created from these solutions will be returned to participating practices. Participating practices will be able to put forward projects that they are keen to be part of through their associations and affiliations. At times, practices that are part of the Magentus Research Program may be invited to use tools that utilise data and/or artificial intelligence solutions before they are made available to other customers and will be invited to provide feedback and explore other opportunities for collaboration on new innovation in these areas.
All historical and future data that exists within a practice’s practice management database that is accessible via the Magentus software, has the potential to be included in the projects that we work on. If a practice decides in the future to opt-out of the Magentus Research Program, no data from the point in time that the practice elects to opt-out, will be used in any future project as part of the Magentus Research Program.
Last Updated: December 2025